NO20080536L - Oksazolidinonderivater og deres anvendelse som antibiotika - Google Patents

Oksazolidinonderivater og deres anvendelse som antibiotika

Info

Publication number
NO20080536L
NO20080536L NO20080536A NO20080536A NO20080536L NO 20080536 L NO20080536 L NO 20080536L NO 20080536 A NO20080536 A NO 20080536A NO 20080536 A NO20080536 A NO 20080536A NO 20080536 L NO20080536 L NO 20080536L
Authority
NO
Norway
Prior art keywords
compounds
antibiotics
different meanings
gram
oxazolidinone derivatives
Prior art date
Application number
NO20080536A
Other languages
English (en)
Norwegian (no)
Inventor
Antonio Guglietta
Montserrat Cano
Albert Palomer
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34982564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20080536(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of NO20080536L publication Critical patent/NO20080536L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20080536A 2005-06-27 2008-01-28 Oksazolidinonderivater og deres anvendelse som antibiotika NO20080536L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05105714A EP1745784A1 (en) 2005-06-27 2005-06-27 Oxazolidinone derivatives and use thereof as antibiotics
PCT/EP2006/063541 WO2007000432A1 (en) 2005-06-27 2006-06-26 Oxazolidinone derivatives and use thereof as antibiotics

Publications (1)

Publication Number Publication Date
NO20080536L true NO20080536L (no) 2008-03-14

Family

ID=34982564

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080536A NO20080536L (no) 2005-06-27 2008-01-28 Oksazolidinonderivater og deres anvendelse som antibiotika

Country Status (23)

Country Link
US (1) US7759351B2 (sl)
EP (2) EP1745784A1 (sl)
JP (1) JP2008543963A (sl)
KR (1) KR20080020696A (sl)
CN (1) CN101248067A (sl)
AR (1) AR054625A1 (sl)
AT (1) ATE442366T1 (sl)
AU (1) AU2006263880A1 (sl)
BR (1) BRPI0612559A2 (sl)
CA (1) CA2612969A1 (sl)
CY (1) CY1109544T1 (sl)
DE (1) DE602006009112D1 (sl)
DK (1) DK1902050T3 (sl)
ES (1) ES2333469T3 (sl)
HK (1) HK1116482A1 (sl)
MX (1) MX2007016329A (sl)
NO (1) NO20080536L (sl)
PL (1) PL1902050T3 (sl)
PT (1) PT1902050E (sl)
RU (1) RU2417223C2 (sl)
SI (1) SI1902050T1 (sl)
TW (1) TWI324603B (sl)
WO (1) WO2007000432A1 (sl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009079797A1 (en) 2007-12-26 2009-07-02 Critical Outcome Technologies, Inc. Compounds and method for treatment of cancer
EP2318406B1 (en) 2008-07-17 2016-01-27 Critical Outcome Technologies, Inc. Thiosemicarbazone inhibitor compounds and cancer treatment methods
EP2367820B1 (en) 2008-11-20 2016-09-21 Panacea Biotec Limited Novel antimicrobial agents
US8906913B2 (en) 2009-06-26 2014-12-09 Panacea Biotec Limited Azabicyclohexanes
US8987272B2 (en) 2010-04-01 2015-03-24 Critical Outcome Technologies Inc. Compounds and method for treatment of HIV
CN105899496A (zh) * 2013-07-11 2016-08-24 安达卢西亚健康服务部 用作ppar配体的恶唑烷酮衍生物
CN103420995B (zh) * 2013-09-07 2015-07-01 吉首大学 噁唑烷酮-烷胺基-呋喃酮型化合物及其制法和用途
CN104447730B (zh) * 2014-12-05 2017-11-07 广东东阳光药业有限公司 噁唑烷酮类化合物及其在药物中的应用
TWI614256B (zh) 2017-05-26 2018-02-11 合成四氫異喹啉噁唑烷的方法
RU2742765C1 (ru) * 2017-09-28 2021-02-10 ЭлДжи КЕМ, ЛТД. Способ получения промежуточного соединения для синтеза лекарственного средства
US20230219941A1 (en) 2020-06-18 2023-07-13 Akagera Medicines, Inc. Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof
CN115466253B (zh) * 2021-06-16 2024-08-20 沈阳药科大学 含二硫代氨基甲酸酯结构的噁唑烷酮类化合物及其制备方法
CN113880821B (zh) * 2021-10-29 2024-03-12 南京碳硅人工智能生物医药技术研究院有限公司 一类双光子荧光探针对癫痫脑内次氯酸特征成像的荧光探针设计及其合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6686363B2 (en) * 2001-11-29 2004-02-03 Kyorin Pharmaceutical Co., Ltd. Cyclopropyl containing oxazolidinone antibiotics and derivatives thereof
AU2003272071A1 (en) * 2002-07-11 2004-02-02 Wockhardt Limited Antibacterial substituted cyanomethyl (ene) piperidinophenyl oxazolidinones, process or their preparation, and pharmaceutical compositions containing them
WO2004089944A1 (en) * 2003-04-07 2004-10-21 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials

Also Published As

Publication number Publication date
EP1902050B1 (en) 2009-09-09
DK1902050T3 (da) 2010-01-04
CN101248067A (zh) 2008-08-20
CY1109544T1 (el) 2014-08-13
KR20080020696A (ko) 2008-03-05
AU2006263880A1 (en) 2007-01-04
ATE442366T1 (de) 2009-09-15
MX2007016329A (es) 2008-03-10
RU2008102597A (ru) 2009-08-10
RU2417223C2 (ru) 2011-04-27
EP1745784A1 (en) 2007-01-24
BRPI0612559A2 (pt) 2010-11-23
US7759351B2 (en) 2010-07-20
WO2007000432A1 (en) 2007-01-04
PL1902050T3 (pl) 2010-03-31
SI1902050T1 (sl) 2010-01-29
AR054625A1 (es) 2007-07-04
JP2008543963A (ja) 2008-12-04
HK1116482A1 (en) 2008-12-24
CA2612969A1 (en) 2007-01-04
EP1902050A1 (en) 2008-03-26
US20090062266A1 (en) 2009-03-05
DE602006009112D1 (de) 2009-10-22
TWI324603B (en) 2010-05-11
TW200740800A (en) 2007-11-01
PT1902050E (pt) 2009-11-27
ES2333469T3 (es) 2010-02-22

Similar Documents

Publication Publication Date Title
NO20080536L (no) Oksazolidinonderivater og deres anvendelse som antibiotika
WO2002059116A3 (en) Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
NO20085067L (no) 4,5-difenyl-pyrimidinyl substituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
LTC1699784I2 (lt) Nauji oksazolidinono dariniai
NO20061050L (no) 7-(4-Substituerte-3-Cyclopropylaminometyl-1-Pyrrolidin yl)Kinolon-karboksylsyrederivater
NO20074993L (no) Bisykliske [3 0 1]heteroaryl amider som type 1 glysin transport inhibitorer
WO2006087543A8 (en) Antibacterial piperidine derivatives
HK1091831A1 (en) Isoxazole compounds as inhibitors of heat shock proteins
NO20055421L (no) Kinolinderivater som fosfodiestrase-inhibitorer
WO2007023507A3 (en) Oxazolidinones bearing antimicrobial activity composition and methods of preparation
WO2007069020A3 (en) N-hydroxyamide derivatives possessing antibacterial activity
NO20082629L (no) Macrocyklisk factor VIIa-inhibitorer anvendbare som antikoagulanter
NO331012B1 (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
ATE476431T1 (de) Piperidin- und azetidinderivate als glyt1- inhibitoren
NO20035791L (no) Nye derivater av oksazolidinoner som antibakterielle midler
NO20075270L (no) Antibakterielle amid-makrocykler V
NO20070870L (no) Oksazolidinonforbindelser og sammensetninger og fremgangsmater relatert dertil
GEP20084437B (en) Novel lincomycin derivatives possessing antimicrobial activity
SG166798A1 (en) Quinolone derivatives as antibacterial agents
NO20044548L (no) Fremgangsmate for fremstilling av 6-alkaliden-penemderivater
TW200612907A (en) New compounds
EP1336611A4 (en) DIHALOGENIC COMPOUNDS
NO20014234L (no) Pyrazol-3-on-derivater som faktor-Xa-inhibitorer
NO167456B (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse 7-(3-amino-1-pyrrolidinyl)-8-brom-1-syklopropyl-6-fluor-1,4-dihydro-4-okso-3-quinolinkarboksylsyre
EA200800152A1 (ru) Производные хинолина в качестве антибактериальных агентов

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application